THE β-TAIL DOMAIN (βTD) REGULATES PHYSIOLOGIC LIGAND BINDING TO INTEGRIN CD11b/CD18

Crystallographic and electron microscopy studies revealed genuflexed (bent) integrins in both unliganded (inactive) and physiologic ligand-bound (active) states, suggesting that local conformational changes are sufficient for activation. Herein we have explored the role of local changes in the contact region between the membrane-proximal β−tail domain (βTD) and the ligand-binding βA domain of the bent conformation, in regulating interaction of integrin CD11b/CD18 (αMβ2) with its physiologic ligand iC3b. We replaced the βTD CD loop residues D658GMD of the CD18 (β2) subunit with the equivalent D672SSG of the β3 subunit, with AGAA or with NGTD, expressed the respective heterodimeric receptors either transiently in epithelial HEK293T cells or stably in leukocytes (K562), and measured their ability to bind iC3b and to conformation-sensitive mAbs. In the presence of the physiologic divalent cations Ca 2+ plus Mg 2+ (at 1mM each), the modified integrins showed increased (in HEK293) or constitutive (in K562) binding to iC3b, compared to wild-type receptors. K562 expressing the βTD-modified integrins bound in Ca 2+ /Mg 2+ to the βA-directed high-affinity reporter mAb 24 but not to mAb KIM127, a reporter of the genu-straightened state. These data identify a role for the membrane proximal βTD as an allosteric modulator of integrin activation.